Daily News Podcast

Is it time to revise ASCVD cardiovascular risk threshold?


 

Researchers suggest that revising the threshold for high CV risk from 7.5% at 10 years to 10% at 10 years. Also today, psoriasis adds to risk of CV procedures and surgery in hypertension, sickle cell disease gene therapy seen advancing, and early appendectomy is linked with a reduction in risk for developing Parkinson’s later in life.

Amazon Alexa
Apple Podcasts
Spotify

Recommended Reading

Cardiomyopathy could be under recognized in lupus
MDedge Hematology and Oncology
Novel blood test for RA prevention?
MDedge Hematology and Oncology
Screening for intimate partner violence
MDedge Hematology and Oncology
Validation for SLE low-disease definition
MDedge Hematology and Oncology
Heather Yeo: Surgical Residency Attrition
MDedge Hematology and Oncology
AKI linked to later dementia
MDedge Hematology and Oncology
Part B scheme raises concerns
MDedge Hematology and Oncology
Palliative care update highlights role of nonspecialists
MDedge Hematology and Oncology
NSAID risk score validated for CV events
MDedge Hematology and Oncology
TENS improves fibromyalgia pain
MDedge Hematology and Oncology